NetTargets
PrivateLast Round
VC Round
May 1, 2024
Total Funding Raised
$7.17M
Company Overview
NetTargets is a biotechnology company that provides a drug discovery platform based on AI-enhanced systems biology to identify novel drug targets and simulate treatment strategies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NetTargets Comparables
Compare NetTargets with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Callio Therapeutics | 83% | |
| Phrontline Biopharma | 83% | |
| Eli Lilly and Company | 75% |
NetTargets Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 1, 2024 | ||||
| Series A | Jun 28, 2021 | ||||
| Pre Seed | Apr 16, 2020 | ||||
| Seed | Oct 25, 2019 |
NetTargets Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DA Value Investment | Series A |
| CKD Venture Capital | Series A |
| Bluepoint Partners | Seed |
| Friend Investment Partners | Pre Seed, Series A |
| GU Equity Partners | Series A |
| We Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 30, 2025
Developing dual-payload ADCs with Debiopharm to treat resistant cancers.
- Oct 30, 2025
Collaborating with Debiopharm on dual-payload Antibody-Drug Conjugates (ADCs).
NetTargets Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NetTargets's valuation, stock price, and market status.
Is NetTargets a public or private company?
NetTargets is a private company.
What is the current stock price of NetTargets?
NetTargets is a private company with no public stock price. No recent secondary market data is available.
How much is NetTargets worth (valuation)?
Valuation information for NetTargets is not publicly available.
Can I buy NetTargets stock?
NetTargets shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NetTargets's last funding round?
NetTargets's most recent funding round was Series A on July 2, 2021.
Who are the main investors in NetTargets?
Key investors in NetTargets include DA Value Investment, CKD Venture Capital, Friend Investment Partners, GU Equity Partners, We Ventures.
Will NetTargets IPO soon?
No public IPO plans have been announced for NetTargets.
How can I track NetTargets secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NetTargets's secondary market activity and sign up for updates.